Pharmacometric modelling is an increasingly used method for analysing the outcome from clinical trials in drug development. The model building process is complex and involves testing, evaluating and diagnosing a range of plausible models aiming to make an adequate inference from the observed data and predictions for future studies and therapy. The aim of this thesis was to advance the approaches used in pharmacometrics by introducing improved models and methods for application in essential parts of model building procedure: (i) structural model development, (ii) stochastic model development and (iii) model diagnostics. As a contribution to the structural model development, a novel flexible structural model for drug absorption, a transit c...
AIMS: A descriptive survey of published population pharmacokinetic and/or pharmacodynamic (PK/PD) an...
Biological medicinal products (BMPs) are a successful class of drugs that are indicated in numerous ...
The use of mathematical models to describe and predict the pharmacokinetics (PK), i.e., what the bod...
Pharmacometric modelling is an increasingly used method for analysing the outcome from clinical tria...
Introduction: The current development strategy of population pharmacokinetic models is a complex and...
Pharmacometrics, the science of quantitative clinical pharmacology, has been recognized as one of th...
Pharmacometric model-based analysis using nonlinear mixed-effects models (NLMEM) has to date mainly ...
Pharmacometrics uses models based on pharmacology, physiology and disease for quantitative analysis ...
Pharmacometric models are increasingly used to improve the efficiency of the drug development proces...
Population pharmacokinetic (PK) – pharmacodynamic (PD) modelling, using nonlinear mixed effects mode...
Pharmacometrics model-based analyses proved to be increasingly useful in drug discovery and developm...
The success rate in clinical development of newer anti-cancer molecules is the lowest compared to ot...
summary:A pharmacodynamic model introduced earlier in the literature for in silico prediction of rif...
This thesis describes the application of pharmacometrics to optimize treatment with existing therapi...
Population PK models aim to describe the change in drug concentration over time for a specific popul...
AIMS: A descriptive survey of published population pharmacokinetic and/or pharmacodynamic (PK/PD) an...
Biological medicinal products (BMPs) are a successful class of drugs that are indicated in numerous ...
The use of mathematical models to describe and predict the pharmacokinetics (PK), i.e., what the bod...
Pharmacometric modelling is an increasingly used method for analysing the outcome from clinical tria...
Introduction: The current development strategy of population pharmacokinetic models is a complex and...
Pharmacometrics, the science of quantitative clinical pharmacology, has been recognized as one of th...
Pharmacometric model-based analysis using nonlinear mixed-effects models (NLMEM) has to date mainly ...
Pharmacometrics uses models based on pharmacology, physiology and disease for quantitative analysis ...
Pharmacometric models are increasingly used to improve the efficiency of the drug development proces...
Population pharmacokinetic (PK) – pharmacodynamic (PD) modelling, using nonlinear mixed effects mode...
Pharmacometrics model-based analyses proved to be increasingly useful in drug discovery and developm...
The success rate in clinical development of newer anti-cancer molecules is the lowest compared to ot...
summary:A pharmacodynamic model introduced earlier in the literature for in silico prediction of rif...
This thesis describes the application of pharmacometrics to optimize treatment with existing therapi...
Population PK models aim to describe the change in drug concentration over time for a specific popul...
AIMS: A descriptive survey of published population pharmacokinetic and/or pharmacodynamic (PK/PD) an...
Biological medicinal products (BMPs) are a successful class of drugs that are indicated in numerous ...
The use of mathematical models to describe and predict the pharmacokinetics (PK), i.e., what the bod...